Literature DB >> 27165914

State of Cerebrovascular Autoregulation Correlates with Outcome in Severe Infant/Pediatric Traumatic Brain Injury.

Carmen Nagel1, Jennifer Diedler2, Ines Gerbig3, Ellen Heimberg3, Martin U Schuhmann4, Konstantin Hockel2.   

Abstract

OBJECTIVE: It could be shown in adults with severe traumatic brain injury (TBI) that the functional status of cerebrovascular autoregulation (AR), determined by the pressure reactivity index (PRx), correlates with and even predicts outcome. We investigated PRx and its correlation with outcome in infant and pediatric TBI. Methods Ten patients (median age 2.8 years, range 1 day to 14 years) with severe TBI (Glasgow Coma Scale score <9 at presentation) underwent long-term computerized intracranial pressure (ICP) and mean arterial pressure (MAP) monitoring using dedicated software for continuous determination of cerebral perfusion pressure (CPP) and PRx. Outcome was determined at discharge and at follow-up at 6 months using the Glasgow Outcome Scale (GOS) score.
RESULTS: Median monitoring time was 182 h (range 22-355 h). Seven patients underwent decompressive craniectomy to control ICP during treatment in the intensive care unit. Favorable outcome (GOS 4 and 5) was reached in 4 patients, an unfavorable outcome (GOS 1-3) in 6 patients. When dichotomized to outcome, no correlation was found with ICP and CPP, but median PRx correlated well with outcome (r = -0.79, p = 0.006) and tended to be lower for GOS 4 and 5 (-0.04) than for GOS 1-3 (0.32; p = 0.067).
CONCLUSION: The integrity of AR seems to play the same fundamental role after TBI in the pediatric population as in adults and should be determined routinely. It carries an important prognostic value. PRx seems to be an ideal candidate parameter to guide treatment in the sense of optimizing CPP, aiming at improvement of cerebrovascular autoregulation (CPPopt concept).

Entities:  

Keywords:  Cerebral autoregulation; Outcome; PRx; Pediatric; Pressure reactivity; Traumatic brain injury

Mesh:

Year:  2016        PMID: 27165914     DOI: 10.1007/978-3-319-22533-3_48

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  6 in total

1.  The authors reply.

Authors:  Abhijit V Lele; Arraya Watanitanon; Viharika Lakireddy; Crystalyn Clark-Bell; Anne Moore; Jerry J Zimmerman; Randall M Chesnut; William Armstead; Monica S Vavilala
Journal:  Pediatr Crit Care Med       Date:  2019-07       Impact factor: 3.624

Review 2.  Pediatric Traumatic Brain Injury: An Update on Preclinical Models, Clinical Biomarkers, and the Implications of Cerebrovascular Dysfunction.

Authors:  Divine C Nwafor; Allison L Brichacek; Chase H Foster; Brandon P Lucke-Wold; Ahsan Ali; Mark A Colantonio; Candice M Brown; Rabia Qaiser
Journal:  J Cent Nerv Syst Dis       Date:  2022-05-22

Review 3.  Anatomical and Physiological Differences between Children and Adults Relevant to Traumatic Brain Injury and the Implications for Clinical Assessment and Care.

Authors:  Anthony A Figaji
Journal:  Front Neurol       Date:  2017-12-14       Impact factor: 4.003

Review 4.  Monitoring and Measurement of Intracranial Pressure in Pediatric Head Trauma.

Authors:  Sarah Hornshøj Pedersen; Alexander Lilja-Cyron; Ramona Astrand; Marianne Juhler
Journal:  Front Neurol       Date:  2020-01-14       Impact factor: 4.003

5.  Monitoring of cerebrovascular pressure reactivity in children may predict neurologic outcome after hypoxic-ischemic brain injury.

Authors:  Felix Neunhoeffer; Martin U Schuhmann; Julian Zipfel; Dorothea Hegele; Konstantin Hockel; Susanne R Kerscher; Ellen Heimberg; Marek Czosnyka
Journal:  Childs Nerv Syst       Date:  2022-06-09       Impact factor: 1.532

6.  Glycemia Is Related to Impaired Cerebrovascular Autoregulation after Severe Pediatric Traumatic Brain Injury: A Retrospective Observational Study.

Authors:  Adam M H Young; Hadie Adams; Joseph Donnelly; Mathew R Guilfoyle; Helen Fernandes; Mathew R Garnett; Marek Czosnyka; Peter Smielewski; Mark Plummer; Shruti Agrawal; Peter J Hutchinson
Journal:  Front Pediatr       Date:  2017-09-25       Impact factor: 3.418

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.